PARADIGM CAPITAL MANAGEMENT INC/NY - ORTHOPEDIATRICS CORP ownership

ORTHOPEDIATRICS CORP's ticker is KIDS and the CUSIP is 68752L100. A total of 116 filers reported holding ORTHOPEDIATRICS CORP in Q3 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARADIGM CAPITAL MANAGEMENT INC/NY ownership history of ORTHOPEDIATRICS CORP
ValueSharesWeighting
Q3 2023$1,900,800
+76.2%
59,400
+141.5%
0.11%
+75.8%
Q2 2023$1,078,710
-1.0%
24,6000.0%0.06%
-13.9%
Q1 2023$1,089,534
+11.5%
24,6000.0%0.07%
+10.8%
Q4 2022$977,358
-13.9%
24,6000.0%0.06%
-20.7%
Q3 2022$1,135,000
+6.9%
24,6000.0%0.08%
+13.9%
Q2 2022$1,062,000
-20.0%
24,6000.0%0.07%0.0%
Q1 2022$1,328,000
-9.8%
24,6000.0%0.07%
+9.1%
Q4 2021$1,472,000
-8.7%
24,6000.0%0.07%
-20.5%
Q3 2021$1,612,000
+3.7%
24,6000.0%0.08%
+10.7%
Q2 2021$1,554,000
+29.6%
24,6000.0%0.08%
+21.0%
Q1 2021$1,199,000
+131.0%
24,600
+95.2%
0.06%
+100.0%
Q4 2020$519,000
-10.4%
12,6000.0%0.03%
-36.7%
Q3 2020$579,000
+4.9%
12,6000.0%0.05%
-3.9%
Q2 2020$552,000
+10.4%
12,6000.0%0.05%
-15.0%
Q1 2020$500,000
+1.4%
12,600
+20.0%
0.06%
+57.9%
Q4 2019$493,000
+32.9%
10,5000.0%0.04%
+15.2%
Q3 2019$371,000
-9.3%
10,5000.0%0.03%
-10.8%
Q2 2019$409,000
-11.9%
10,5000.0%0.04%
-9.8%
Q1 2019$464,000
+26.8%
10,5000.0%0.04%
+13.9%
Q4 2018$366,000
-4.9%
10,5000.0%0.04%
+20.0%
Q3 2018$385,000
+37.5%
10,5000.0%0.03%
+30.4%
Q2 2018$280,00010,5000.02%
Other shareholders
ORTHOPEDIATRICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 604,275$26,763,3392.94%
AWM Investment Company, Inc. 395,658$17,523,6932.37%
Brown Capital Management 3,295,207$145,944,7182.18%
FORMULA GROWTH LTD 130,258$5,769,1271.86%
BRAIDWELL LP 998,871$44,239,9971.46%
First Light Asset Management, LLC 301,579$13,356,9341.20%
Granahan Investment Management 518,653$22,971,1410.70%
RIVERBRIDGE PARTNERS LLC 1,042,453$46,170,2430.65%
Nebula Research & Development LLC 4,605$203,9550.36%
DF DENT & CO INC 339,839$15,051,4730.21%
View complete list of ORTHOPEDIATRICS CORP shareholders